{
  "personas": [
    {
      "id": "clinical",
      "name": "Clinical Development",
      "description": "Intelligence for protocol optimization and clinical study success",
      "icon": "flask",
      "color": "blue",
      "featured": true
    },
    {
      "id": "regulatory",
      "name": "Regulatory Affairs",
      "description": "Streamlined preparation for regulatory submissions and meetings",
      "icon": "file-check",
      "color": "green"
    },
    {
      "id": "statistical",
      "name": "Biostatistics",
      "description": "Advanced statistical modeling and endpoint optimization",
      "icon": "bar-chart",
      "color": "purple"
    },
    {
      "id": "medical",
      "name": "Medical Affairs",
      "description": "Evidence synthesis and strategic scientific communications",
      "icon": "stethoscope",
      "color": "teal"
    },
    {
      "id": "investor",
      "name": "Biotech Investor",
      "description": "Decision-grade intelligence for investment in clinical-stage companies",
      "icon": "trending-up",
      "color": "amber",
      "featured": true,
      "new": true
    },
    {
      "id": "executive",
      "name": "Executive Suite",
      "description": "Strategic decision support for portfolio management",
      "icon": "briefcase",
      "color": "indigo"
    }
  ],
  "reportTypes": [
    {
      "id": "success-prediction",
      "name": "Trial Success Prediction",
      "description": "AI-powered probability models for trial outcomes",
      "icon": "percent"
    },
    {
      "id": "protocol-optimization",
      "name": "Protocol Design Optimization",
      "description": "Evidence-based protocol enhancement recommendations",
      "icon": "file-edit"
    },
    {
      "id": "endpoint-selection",
      "name": "Endpoint Intelligence",
      "description": "Optimal endpoint selection with statistical power analysis",
      "icon": "target"
    },
    {
      "id": "regulatory-package",
      "name": "Regulatory Bundle",
      "description": "Complete documentation package for regulatory submissions",
      "icon": "folder"
    },
    {
      "id": "investment-analysis",
      "name": "Investment Analysis",
      "description": "Risk-adjusted valuation models for biotech assets",
      "icon": "line-chart",
      "new": true
    },
    {
      "id": "competitive-intelligence",
      "name": "Competitive Intelligence",
      "description": "Landscape analysis with differentiation scoring",
      "icon": "users"
    }
  ],
  "featuredReports": [
    {
      "id": "clinical-protocol-optimizer",
      "name": "Protocol Optimizer Suite",
      "description": "Comprehensive optimization of trial design with success prediction",
      "persona": "clinical",
      "type": "protocol-optimization",
      "thumbnail": "/images/reports/protocol-optimizer.png"
    },
    {
      "id": "investor-portfolio-overview",
      "name": "Biotech Portfolio Analysis",
      "description": "Investment-grade intelligence for clinical asset evaluation",
      "persona": "investor",
      "type": "investment-analysis",
      "thumbnail": "/images/reports/investor-portfolio.png",
      "new": true
    },
    {
      "id": "regulatory-submission-bundle",
      "name": "IND Submission Bundle",
      "description": "Complete package for FDA IND submissions with intelligent validation",
      "persona": "regulatory",
      "type": "regulatory-package",
      "thumbnail": "/images/reports/ind-bundle.png"
    }
  ]
}